GC Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- October 05, 2024
- Vertical
- Biopharmaceuticals
- Funding URL
- View Funding Page
- Funding Amount:
- $65,000,000
Company Info
- Company Description
- GC Therapeutics uses synthetic biology to program patient-derived stem cells into various cell types in an efficient and scalable manner.
- Market
- Cell therapy-based medicines
- Location
- Cambridge, MA, USA
- Coinvestors
- Cercano Management, Cormorant Asset Management, Medical Excellence Capital, Mubadala Capital, Pear Ventures